Falcone D J, Borth W, McCaffrey T A, Mathew J, McAdam K
Department of Pathology, Cornell Medical College, New York, New York.
J Biol Chem. 1994 Dec 23;269(51):32660-6.
The activation of plasminogen by macrophage is regulated by their expression of receptors for urokinase and plasmin(ogen). In these studies we have examined plasmin(ogen) binding to adherent human THP-1 macrophage. Plasmin bound to the THP-1 cells in a time- and dose-dependent manner (Kd 15.8 +/- 6.2 nM; Bmax 1.4 +/- 0.3 x 10(6)/cell). The lysine analog epsilon-aminocaproic acid competitively inhibited plasmin binding. The fraction of membrane-bound plasmin, however, became increasingly resistant to displacement with epsilon-aminocaproic acid. Over a 24-h period, membrane-bound plasmin activity fell 80% despite the presence of catalytically active plasmin in the incubation media. The loss of receptor-bound plasmin activity was not due to proteolytic alterations of its receptor since 125I-Lys-plasminogen bound to THP-1 cells pretreated with plasmin with similar affinity as to untreated cells. Following a 24-h incubation of 125I-Lys-plasminogen or 125I-plasmin with THP-1 cells, several degradative fragments were apparent in their conditioned media. The smaller degradative fragments (28 and 36 kDa) lacked cell binding activity and were demonstrated to be active by casein-zymography. A 48-kDa fragment bound to cells in a lysine-dependent manner but was not active. In contrast, phenylmethylsulfonyl fluoride-inactivated 125I-plasmin retained its binding activity over 24 h, and degradative fragments were not present in the conditioned media. The binding of 125I-Lys-plasmin(ogen) to THP-1 cells was also examined in the presence of excess alpha 2 plasmin inhibitor. Despite the absence of fluid-phase plasmin activity, membrane-bound 125I-Lys-plasmin(ogen) decreased over 24 h. At 24 h a radiolabeled 48-kDa fragment was observed in the conditioned media and together with 125I-Lys-plasmin(ogen) was bound to cells. Unlike 125I-Lys-plasmin, the 48-kDa fragment did not form a complex with alpha 2 plasmin inhibitor. Thus, autoproteolysis of receptor-bound plasmin results in fragments with truncated physiologic properties that possess either cell binding or catalytic activities. We propose that autoproteolysis is a mechanism for regulating membrane-bound plasmin activity.
巨噬细胞对纤溶酶原的激活作用受其尿激酶和纤溶酶(原)受体表达的调控。在这些研究中,我们检测了纤溶酶(原)与贴壁的人THP - 1巨噬细胞的结合情况。纤溶酶以时间和剂量依赖性方式与THP - 1细胞结合(解离常数Kd为15.8±6.2 nM;最大结合量Bmax为1.4±0.3×10⁶/细胞)。赖氨酸类似物ε - 氨基己酸竞争性抑制纤溶酶的结合。然而,膜结合纤溶酶的比例对ε - 氨基己酸的置换作用变得越来越有抗性。在24小时内,尽管孵育培养基中存在具有催化活性的纤溶酶,但膜结合纤溶酶活性下降了80%。受体结合的纤溶酶活性丧失并非由于其受体的蛋白水解改变,因为¹²⁵I - 赖氨酸 - 纤溶酶原与用纤溶酶预处理的THP - 1细胞结合的亲和力与未处理细胞相似。¹²⁵I - 赖氨酸 - 纤溶酶原或¹²⁵I - 纤溶酶与THP - 1细胞孵育24小时后,在其条件培养基中出现了几个降解片段。较小的降解片段(28 kDa和36 kDa)缺乏细胞结合活性,并且通过酪蛋白酶谱法证明具有活性。一个48 kDa的片段以赖氨酸依赖性方式与细胞结合,但无活性。相比之下,苯甲基磺酰氟灭活的¹²⁵I - 纤溶酶在24小时内保持其结合活性,且条件培养基中不存在降解片段。在过量α₂纤溶酶抑制剂存在的情况下,也检测了¹²⁵I - 赖氨酸 - 纤溶酶(原)与THP - 1细胞的结合情况。尽管不存在液相纤溶酶活性,但膜结合的¹²⁵I - 赖氨酸 - 纤溶酶(原)在24小时内减少。在24小时时,在条件培养基中观察到一个放射性标记的48 kDa片段,并且它与¹²⁵I - 赖氨酸 - 纤溶酶(原)一起与细胞结合。与¹²⁵I - 赖氨酸 - 纤溶酶不同,48 kDa片段不与α₂纤溶酶抑制剂形成复合物。因此,受体结合的纤溶酶的自蛋白水解作用导致具有截短生理特性的片段,这些片段具有细胞结合或催化活性。我们提出自蛋白水解是调节膜结合纤溶酶活性的一种机制。